A Phase I, Single-Center, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of NRM8499 Administered as Single Dose to Healthy Male and Female Subjects

Trial Profile

A Phase I, Single-Center, Double-Blind, Randomized, Placebo-Controlled Clinical Trial to Investigate the Safety, Tolerability and Pharmacokinetics of NRM8499 Administered as Single Dose to Healthy Male and Female Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Oct 2017

At a glance

  • Drugs ALZ 801 (Primary) ; Tramiprosate
  • Indications Alzheimer's disease
  • Focus Adverse reactions; Pharmacokinetics
  • Sponsors BELLUS Health
  • Most Recent Events

    • 23 Oct 2017 Results published in the Clinical Pharmacokinetics
    • 20 Mar 2015 Results presented at the 12th International Conference on Alzheimer's and Parkinson's Diseases, according to an Alzheon media release.
    • 31 Jan 2011 Inerim results have been reported for Part 1-3 (67 patients) in a BELLUS Health media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top